Former Amgen executive Dr. Geoffrey Slaff joins PBS Biotech, Inc. Scientific Advisory Board
Biotech industry expertise in process development, engineering and quality provides technical and quality leadership to the fast growing single-use bioreactor firm.
Camarillo, California, June 1, 2011 – PBS Biotech, Inc., a developer of state of the art single-use bioreactors for the fast growing biotechnology market, announced today Dr. Geoffrey Slaff, recently retired Senior Vice President (SVP) of Process and Product Engineering at Amgen, Inc., the global biotechnology leader with over $15B in sales and 17,000 employees, has joined the firm’s Scientific Advisory Board (SAB). The SAB includes accomplished executives, business leaders, and scientists from the leading academic institutes and biopharmaceutical companies, and provides both technical and business expertise to the PBS Biotech team.Dr. Slaff brings a wide range of expertise and experience to PBS Biotech from his 27 years in bioprocess development, product engineering, and quality in biotechnology industry. He also led the global quality operations at Amgen as SVP of Quality insuring Amgen’s production sites met corporate and regulatory requirements for the production of products used to treat patients suffering from cancer, kidney disease, bone disease and other serious illnesses.
PBS Biotech’s single-use bioreactors help reduce costs and accelerate time to market for worldwide manufacturers of biological drugs, vaccines and biosimilars. “Geoff is recognized as a leader and expert in quality and process throughout all stages of biopharmaceutical product development and manufacturing. He is a tremendous asset to the company by helping us reach the next level of success as our products are commercialized and adopted in the market,” said Dr. Brian Lee, president and co-founder of PBS Biotech.
“The adoption of single-use bioreactors is expected to grow dramatically in the next few years as the industry embraces the inherent benefits of this technology,’” said Dr. Slaff. “PBS Biotech has developed very interesting and innovative technology to deliver the next generation single-use bioreactors which can offer cost savings, process flexibility and production efficiency” he said.
Dr. Slaff earned a PhD in biochemical engineering from University of Pennsylvania and worked as Executive Director, Research and Development at Serono International and VP at Synergen prior to joining Amgen.
About PBS Biotech
PBS Biotech, Inc. is a US corporation that designs and manufactures fully scalable and easy to use single-use bioreactors used by global biotechnology organizations. The company has patented innovative industrial designs and advanced software driven control systems that produce low shear cell culture solutions improving operational flexibility and process efficiency, reducing operating costs and accelerating time to market for biotechnology customers. With headquarters in Camarillo, CA., PBS Biotech is a member of the BioProcess Systems Alliance (BPSA).
Contact: Rick Sullivan, VP Sales & Marketing